Gentex (GNTX) Competitors $27.67 -0.10 (-0.36%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$27.64 -0.03 (-0.11%) As of 09/3/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GNTX vs. VC, ADNT, ALV, APTV, BC, BWA, ITT, LEA, MGA, and ALSNShould you be buying Gentex stock or one of its competitors? The main competitors of Gentex include Visteon (VC), Adient (ADNT), Autoliv (ALV), Aptiv (APTV), Brunswick (BC), BorgWarner (BWA), ITT (ITT), Lear (LEA), Magna International (MGA), and Allison Transmission (ALSN). Gentex vs. Its Competitors Visteon Adient Autoliv Aptiv Brunswick BorgWarner ITT Lear Magna International Allison Transmission Gentex (NASDAQ:GNTX) and Visteon (NASDAQ:VC) are both mid-cap auto/tires/trucks companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability. Is GNTX or VC a better dividend stock? Gentex pays an annual dividend of $0.48 per share and has a dividend yield of 1.7%. Visteon pays an annual dividend of $1.10 per share and has a dividend yield of 0.9%. Gentex pays out 27.1% of its earnings in the form of a dividend. Visteon pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do analysts rate GNTX or VC? Gentex presently has a consensus price target of $28.63, indicating a potential upside of 3.45%. Visteon has a consensus price target of $116.00, indicating a potential downside of 5.47%. Given Gentex's higher probable upside, equities research analysts clearly believe Gentex is more favorable than Visteon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gentex 0 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.44Visteon 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.85 Which has more volatility and risk, GNTX or VC? Gentex has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Visteon has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Is GNTX or VC more profitable? Gentex has a net margin of 16.82% compared to Visteon's net margin of 7.61%. Visteon's return on equity of 23.22% beat Gentex's return on equity.Company Net Margins Return on Equity Return on Assets Gentex16.82% 16.86% 14.90% Visteon 7.61%23.22%10.65% Does the media prefer GNTX or VC? In the previous week, Gentex had 1 more articles in the media than Visteon. MarketBeat recorded 13 mentions for Gentex and 12 mentions for Visteon. Gentex's average media sentiment score of 1.47 beat Visteon's score of 1.44 indicating that Gentex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gentex 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Visteon 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, GNTX or VC? Gentex has higher earnings, but lower revenue than Visteon. Visteon is trading at a lower price-to-earnings ratio than Gentex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGentex$2.31B2.63$404.49M$1.7715.63Visteon$3.87B0.87$274M$10.4911.70 Do institutionals and insiders hold more shares of GNTX or VC? 86.8% of Gentex shares are owned by institutional investors. Comparatively, 99.7% of Visteon shares are owned by institutional investors. 0.5% of Gentex shares are owned by insiders. Comparatively, 2.0% of Visteon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryGentex and Visteon tied by winning 9 of the 18 factors compared between the two stocks. Get Gentex News Delivered to You Automatically Sign up to receive the latest news and ratings for GNTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GNTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNTX vs. The Competition Export to ExcelMetricGentexAUTO/TRUCK IndustryAuto SectorNASDAQ ExchangeMarket Cap$6.15B$6.37B$19.60B$9.76BDividend Yield1.71%2.36%2.65%4.49%P/E Ratio15.6322.2716.4526.60Price / Sales2.6318.9218.05161.15Price / Cash12.7631.7320.1528.92Price / Book2.503.013.026.56Net Income$404.49M$180.08M$824.52M$266.04M7 Day Performance-1.71%-2.33%-3.53%-0.89%1 Month Performance5.85%7.94%3.76%4.34%1 Year Performance-9.78%33.65%9.34%24.06% Gentex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNTXGentex4.259 of 5 stars$27.67-0.4%$28.63+3.5%-9.4%$6.15B$2.31B15.636,184Positive NewsVCVisteon4.1027 of 5 stars$126.14+0.6%$116.00-8.0%+23.2%$3.44B$3.87B12.0210,000Positive NewsADNTAdient3.596 of 5 stars$25.07+0.8%$21.72-13.3%+9.7%$2.04B$14.41B-9.4670,000ALVAutoliv3.8124 of 5 stars$124.34+0.1%$120.64-3.0%+24.6%$9.55B$10.46B13.6065,200Positive NewsAPTVAptiv4.2328 of 5 stars$78.92+0.6%$81.81+3.7%+13.6%$17.19B$19.71B18.06141,000News CoveragePositive NewsAnalyst ForecastBCBrunswick3.5836 of 5 stars$65.16-1.1%$68.25+4.7%-17.7%$4.26B$5.24B105.1015,000Positive NewsBWABorgWarner4.3486 of 5 stars$43.40+0.6%$39.64-8.6%+29.7%$9.39B$14.09B46.1738,300News CoveragePositive NewsAnalyst UpgradeInsider TradeITTITT4.5454 of 5 stars$169.63-0.7%$179.22+5.7%+26.8%$13.23B$3.63B26.6711,700Positive NewsAnalyst ForecastLEALear4.7829 of 5 stars$109.71+1.1%$113.00+3.0%-5.2%$5.84B$23.31B12.80173,700Trending NewsMGAMagna International4.0353 of 5 stars$46.21+0.3%$42.86-7.2%+9.9%$13.02B$42.84B10.85170,000Positive NewsALSNAllison Transmission4.3852 of 5 stars$88.35-1.1%$98.38+11.3%-1.4%$7.39B$3.20B10.044,000Positive News Related Companies and Tools Related Companies Visteon Competitors Adient Competitors Autoliv Competitors Aptiv Competitors Brunswick Competitors BorgWarner Competitors ITT Competitors Lear Competitors Magna International Competitors Allison Transmission Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GNTX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gentex Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Gentex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
